Federal Register / Vol. 89, No. 174 / Monday, September 9, 2024 / Notices 73101 

Background: The meeting is the tenth 

in a series of Federal advisory 

committee meetings regarding the 

development of recommendations to 

advance equity, justice, and opportunity 

for AA and NHPI communities. The 

meeting is open to the public and will 

be live streamed. The Commission, cochaired by U.S. Health and Human 

Services Secretary Xavier Becerra and 

the U.S. Trade Representative 

Ambassador Katherine Tai, advises the 

President on: the development, 

monitoring, and coordination of 

executive branch efforts to advance 

equity, justice, and opportunity for AA 

and NHPI communities in the United 

States, including efforts to close gaps in 

health, socioeconomic, employment, 

and educational outcomes; policies to 

address and end anti-Asian bias, 

xenophobia, racism, and nativism, and 

opportunities for the executive branch 

to advance inclusion, belonging, and 

public awareness of the diversity and 

accomplishments of AA and NHPI 

people, cultures, and histories; policies, 

programs, and initiatives to prevent, 

report, respond to, and track anti-Asian 

hate crimes and hate incidents; ways in 

which the Federal Government can 

build on the capacity and contributions 

of AA and NHPI communities through 

equitable Federal funding, grantmaking, 

and employment opportunities; policies 

and practices to improve research and 

equitable data disaggregation regarding 

AA and NHPI communities; policies 

and practices to improve language 

access services to ensure AA and NHPI 

communities can access Federal 

programs and services; and strategies to 

increase public-and private-sector 

collaboration, and community 

involvement in improving the safety 

and socioeconomic, health, educational, 

occupational, and environmental wellbeing of AA and NHPI communities. 

Information is available on the 

President’s Advisory Commission on 

Asian Americans, Native Hawaiians, 

and Pacific Islanders website at https:// 

www.hhs.gov/about/whiaanhpi/ 

commission/index.html. The names of 

the members of the President’s Advisory 

Commission on Asian Americans, 

Native Hawaiians, and Pacific Islanders 

are available at https://www.hhs.gov/ 

about/whiaanhpi/commission/ 

commissioners/index.html. 

Purpose of Meeting: The President’s 

Advisory Commission on Asian 

Americans, Native Hawaiians, and 

Pacific Islanders, authorized by 

Executive Order 14031, as amended by 

Executive Order 14109, will meet to 

discuss recommendations by the 

Commission’s six subcommittees on 

ways to advance equity, justice, and 

opportunity for Asian American, Native 

Hawaiian, and Pacific Islander 

communities. The subcommittees are: 

Belonging, Inclusion, Anti-Asian Hate, 

Anti-Discrimination; Data 

Disaggregation and Education; 

Economic Equity; Health Equity; 

Immigration and Citizenship Status; and 

Language Access and Communications. 

Public Participation at Meeting: 

Members of the public may attend the 

meeting virtually. On September 26, the 

Commissioners will hold an in person 

public listening session. Registration is 

required through the following links: 

September 23 (virtual attendance only): 

https://www.eventbrite.com/e/ 

meeting-of-the-presidents-advisorycommission-on-aa-and-nhpis-tickets942107116747 

September 26 (in-person attendance 

only): https://www.eventbrite.com/e/ 

white-house-aa-nhpi-policy-summittickets-942113816787 

Written public comments: Written 

comments are welcomed throughout the 

development of the Commission’s 

recommendations to promote equity, 

justice, and opportunity for Asian 

Americans, Native Hawaiians, and 

Pacific Islanders and may be emailed to 

AANHPICommission@hhs.gov at any 

time. Respond concisely and in plain 

language. You may use any structure or 

layout that presents your information 

well. You may respond to some or all 

of the questions, and you can suggest 

other factors or relevant questions. You 

may also include links to online 

material or interactive presentations. 

Clearly mark any proprietary 

information and place it in its own 

section or file. Your response will 

become government property, and nonproprietary content may be published as 

public record. 

Oral public comments: Individuals 

may submit a request to make an oral 

public comment at the September 26, 

2024, in-person listening session in 

response to the questions below. 

Advance copy of oral public comment 

must be sent via email to 

AANHPICommission@hhs.gov with the 

subject line ‘‘PACAANHPI: In-person 

Response to [insert the issue and 

question]’’ no later than 11:59 p.m. ET 

on Wednesday, September 18, 2024. 

Submissions received after the deadline 

will be considered for oral public 

comment as availability allows. Your 

submitted oral comment will become 

government property and may be 

published as part of the meeting record. 

Registration for oral public comment 

is on a first-come, first-served basis. 

Comments are limited to two (2) 

minutes or less per person. After the 

maximum number of speakers is 

exceeded, individuals registered to 

provide oral comment will be placed on 

a wait list and notified should an 

opening become available. You will be 

notified via email no later than 

September 19, 2024, if you have been 

identified to provide in-person public 

comment. 

The Commission is interested in 

soliciting comments on the following 

questions: 

1. Is information on how to report 

hate crimes to local law enforcement or 

the appropriate Federal authorities 

easily accessible to members of your 

community? 

2. In what ways could local law 

enforcement or relevant Federal 

authorities make hate crimes reporting 

more accessible for vulnerable 

communities, such as utilizing online 

reporting portals, telephone reporting, 

or allowing third parties to submit 

incident reports on behalf of victims? 

3. In what ways could hate crimes 

reporting mechanisms be improved or 

expanded to ensure victims of hate 

crimes are reporting incidents back to 

law enforcement? 

4. When you report a hate crime or 

hate incident to law enforcement or a 

Federal agency, what outcome or 

response do you expect to receive from 

the respective agency? 

Authority: Executive Order 14031 as 

amended by Executive Order 14109. 

The President’s Advisory Commission 

on Asian Americans, Native Hawaiians, 

and Pacific Islanders is governed by 

provisions of the Federal Advisory 

Committee Act, Public Law 92–463, as 

amended (5 U.S.C. App.), which sets 

forth standards for the formation and 

use of Federal advisory committees. 

Krystal Ka‘ai, 

Executive Director, White House Initiative on 

Asian Americans, Native Hawaiians, and 

Pacific Islanders, President’s Advisory 

Commission on Asian Americans, Native 

Hawaiians, and Pacific Islanders. 

[FR Doc. 2024–20047 Filed 9–6–24; 8:45 am] 

BILLING CODE 4150–28–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Committee on Vital and Health 

Statistics 

AGENCY: Centers for Disease Control and 

Prevention, Department of Health and 

Human Services. 

ACTION: Notice of meeting. 

SUMMARY: Pursuant to the Federal 

Advisory Committee Act, the 

Department of Health and Human 


ddrumheller on DSK120RN23PROD with NOTICES1
73102 Federal Register / Vol. 89, No. 174 / Monday, September 9, 2024 / Notices 

Services (HHS) announces the following 

joint meeting of the Subcommittee on 

Privacy, Confidentiality, and Security 

and the Subcommittee on Standards, 

two subcommittees of the National 

Committee on Vital and Health 

Statistics. This meeting is open to the 

public. 

DATES: Thursday, September 19, 2024: 

11 a.m.–5 p.m. EDT and Friday, 

September 20, 2024: 10 a.m.–3 p.m. 

EDT. 

ADDRESSES: Virtual open meeting. The 

public is welcome to obtain the link to 

attend this meeting by following the 

instructions posted on the Committee 

website: https://ncvhs.hhs.gov/ 

meetings/full-committee-meeting-17/. 

FOR FURTHER INFORMATION CONTACT: 

Substantive program information may 

be obtained from Naomi Michaelis, 

MPA, Executive Secretary, NCVHS, 

National Center for Health Statistics, 

Centers for Disease Control and 

Prevention, 3311 Toledo Road, 

Hyattsville, Maryland 20782, or via 

electronic mail to nmichaelis@cdc.gov; 

or by telephone (301) 458–4202. 

Summaries of meetings and a roster of 

Committee members are available on the 

NCVHS website https://ncvhs.hhs.gov/, 

where further information including an 

agenda and instructions to access the 

broadcast of the meeting will be posted. 

Should you require reasonable 

accommodation, please telephone the 

CDC Office of Equal Employment 

Opportunity at (770) 488–3210 as soon 

as possible. 

SUPPLEMENTARY INFORMATION: As 

outlined in its Charter, the National 

Committee on Vital and Health 

Statistics assists and advises the 

Secretary of HHS on health data, data 

standards, statistics, privacy, national 

health information policy, and the 

Department’s strategy to best address 

those issues. The original authorities of 

NCVHS are described at 42 U.S. Code 

242k. Additional authorities were added 

by the Health Insurance Portability and 

Accountability Act of 1996 (HIPAA, 

Pub. L. 104–191, 110 Stat. 1936, Aug. 

21, 1996), under which NCVHS advises 

the Secretary on administrative 

simplification standards, including 

those for privacy, security, adoption and 

implementation of transaction 

standards, unique identifiers, code sets, 

and operating rules adopted under the 

Patient Protection and Affordable Care 

Act (ACA, Pub. L. 111–148, 124 Stat, 

119, Mar. 23, 2010). Included in HIPAA 

is the statutory reporting requirement 

that the Committee submit to Congress 

and make public, a report regarding the 

implementation of part C of title XI of 

the Social Security Act. 

Purpose: The purpose of the Joint 

Meeting of the Subcommittee on 

Privacy, Confidentiality and Security 

and the Subcommittee on Standards is 

to gather information and plan for 

upcoming projects. There will be a 

panel on privacy and security in health 

data access with invited experts. The 

agenda will also include updates from 

the Department, an update on the 

ongoing work of the ICD–11 Workgroup, 

and preparation for the upcoming work 

of the Subcommittee on Standards and 

a celebration of the 75th anniversary of 

the Committee. 

The Committee will reserve time on 

the agenda for public comment. Meeting 

times and topics are subject to change. 

Please refer to the agenda posted on the 

NCVHS website for updates: https://

ncvhs.hhs.gov/meetings/full-committeemeeting-17/. 

Sarah Lessem, 

Executive Director, NCVHS, Senior Data 

Policy Analyst, Office of Science and Data 

Policy, Office of the Assistant Secretary for 

Planning and Evaluation. 

[FR Doc. 2024–20232 Filed 9–6–24; 8:45 am] 

BILLING CODE 4150–05–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse; 

Notice of Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Drug Abuse, Initial Review Group; Career 

Development Education and Training Study 

Section. 

Date: October 24–25, 2024. 

Time: 9:30 a.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Health, 

National Institute on Drug Abuse, 301 North 

Stonestreet Avenue, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Sindhu Kizhakke 

Madathil, Ph.D., Scientific Review Officer, 

Division of Extramural Research, Scientific 

Review Branch, National Institute on Drug 

Abuse, NIH, 301 North Stonestreet Avenue, 

MSC 6021, Bethesda, MD 20892, (301) 827– 

5702, sindhu.kizhakkemadathil@nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; 

Transformative Research on the Basic 

Mechanisms of Polysubstance Use in 

Addiction. 

Date: November 1, 2024. 

Time: 9:30 a.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Health, 

National Institute on Drug Abuse, 301 North 

Stonestreet Avenue, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Sindhu Kizhakke 

Madathil, Ph.D., Scientific Review Officer, 

Division of Extramural Research, Scientific 

Review Branch, National Institute on Drug 

Abuse, NIH, 301 North Stonestreet Avenue, 

MSC 6021, Bethesda, MD 20892, (301) 827– 

5702, sindhu.kizhakkemadathil@nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; 

Addressing HIV in Highest Risk Sexual and 

Gender Minorities. 

Date: November 4, 2024. 

Time: 12:30 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Health, 

National Institute on Drug Abuse, 301 North 

Stonestreet Avenue, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Shareen Amina Iqbal, 

Ph.D., Scientific Review Officer, Division of 

Extramural Research, Scientific Review 

Branch, National Institute on Drug Abuse, 

NIH, 301 North Stonestreet Avenue, MSC 

6021, Bethesda, MD 20892, (301) 443–4577, 

shareen.iqbal@nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; 

Functional Validation and/or 

Characterization of Genes or Variants 

Implicated in Substance Use Disorders and 

NIDA Animal Genomics Program. 

Date: November 19, 2024. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Health, 

National Institute on Drug Abuse, 301 North 

Stonestreet Avenue, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Devon Rene Oskvig, Ph.D., 

Scientific Review Officer, Division of 

Extramural Research, Scientific Review 

Branch, National Institute on Drug Abuse, 

NIH, 301 North Stonestreet Avenue, MSC 

6021, Bethesda, MD 20892, (301) 402–6965, 

devon.oskvig@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.277, Drug Abuse Scientist 

Development Award for Clinicians, Scientist 

Development Awards, and Research Scientist 

Awards; 93.278, Drug Abuse National 

Research Service Awards for Research 

Training; 93.279, Drug Abuse and Addiction 

Research Programs, National Institutes of 

Health, HHS) 


ddrumheller on DSK120RN23PROD with NOTICES1